PVR and neoplasm: It is worth noting that PVR, NECTIN2 have a low correlation with immune checkpoint receptors in tumors, which may be due to the almost non-existent expression of PVR and NECTIN2 on immune cells (Figure 7) and explain the beneficial role of low expression of PVR, NECTIN2 in tumor survival assays.